Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvs.2022.09.004 | DOI Listing |
J Vasc Surg
February 2023
The Mote Vascular Foundation, Inc., Sarasota, FL.
Sci Rep
January 2023
National Institute for Lasers, Plasma and Radiation Physics, 077125, Bucharest, Romania.
A novel laboratory platform has been designed and built for the irradiation of a plasma crystal (PC) with an electron beam (e-beam) having an energy around 10 keV and a current of tens of milliamperes. The pulsed e-beam collimated to a few millimeter-size spot is aimed at a crystal made of dust particles levitated in a radio-frequency (RF) plasma. The platform consists of three vacuum chambers connected in-line, each with different utility: one for generating free electrons in a pulsed hollow-anode Penning discharge, another for the extraction and acceleration of electrons at [Formula: see text] kV and for focusing the e-beam in the magnetic field of a pair of circular coils, and the last one for producing PCs above a RF-driven electrode.
View Article and Find Full Text PDFRev Med Liege
May 2021
Coordinatrice Opérationnelle de l'Equipe Mobile de Soins Continus et Palliatifs, CHU Liège, Belgique.
Progress of medical knowledge pushed the limits of medicine. This raises major ethical issues. The Belgian lawmaker, concerned to ensure the observance of Human Rights, attempted to regulate some of these issues.
View Article and Find Full Text PDFPorcine Health Manag
August 2020
Anses, French Agency for Food, Environmental and Occupational Health & Safety, Ploufragan-Plouzané-Niort Laboratory, Epidemiology, Health and Welfare research unit, F22440 Ploufragan, France.
Mathematical modelling is nowadays a pivotal tool for infectious diseases studies, completing regular biological investigations. The rapid growth of computer technology allowed for development of computational tools to address biological issues that could not be unravelled in the past. The global understanding of viral disease dynamics requires to account for all interactions at all levels, from within-host to between-herd, to have all the keys for development of control measures.
View Article and Find Full Text PDFDiabetes Obes Metab
June 2019
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Aim: To evaluate the lipid-lowering efficacy and safety of evolocumab combined with background atorvastatin in patients with type 2 diabetes mellitus (T2DM) and hyperlipidaemia or mixed dyslipidaemia.
Materials And Methods: BERSON was a double-blind, 12-week, phase 3 study (NCT02662569) conducted in 10 countries. Patients ≥18 to ≤80 years with type T2DM received atorvastatin 20 mg/d and were randomised 2:2:1:1 to evolocumab 140 mg every 2 weeks (Q2W) or 420 mg monthly (QM) or placebo Q2W or QM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!